Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
8510849631!OTHER MEDICAL is a federal award for Dla Troop Support held by Pfizer Inc. Estimated value $925K ($925K obligated). Current period of performance ends Sep 30, 2025. Place of performance: NEW YORK NY.
Recompete timing
PublicCurrent PoP ended Sep 30, 2025 (325 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordPfizer Inc — $3.2B obligated across 1,961 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SPE2D024F0552?
SPE2D024F0552 (8510849631!other medical) is a Dla Troop Support award with a potential value of $925K, currently held by Pfizer Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is SPE2D0-24-F-0552?
SPE2D0-24-F-0552 is the dashed form of PIID SPE2D024F0552 (8510849631!other medical), held by Pfizer Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded SPE2D024F0552?
Dla Troop Support awarded SPE2D024F0552 to Pfizer Inc (potential $925K).
Who is the incumbent on SPE2D024F0552?
Pfizer Inc is the incumbent with $3.2B across 1961 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2025.
When does Pfizer Inc’s SPE2D024F0552 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
